Based on this, the hypothesis that YXF alleviates myocardial fibrosis in DCM by upregulating miR‐133a and inhibiting the TGF‐β/Smads signaling pathway deserves further investigation. Here, TGFB1 is linked to familial dilated cardiomyopathy.